Increased ratio of serum matrix metalloproteinase-9 against TIMP-1 predicts poor wound healing in diabetic foot ulcers.

OBJECTIVE Little is known about serum concentrations of Matrix Metalloproteinase-9 (MMP-9), MMP-2, TIMP-1 and TIMP-2 in diabetic patients with foot ulcers. This study demonstrates their relationship with wound healing. METHODS Ninety-four patients with diabetic foot ulcers were recruited in the study. Serum MMP-9, MMP-2, TIMP-1 and TIMP-2 were measured at the first clinic visit and the end of 4-week treatment and followed up till 12 weeks. According to the decreasing rate of ulcer healing area at the fourth week, we divided those cases into good and poor healers. Through analyses, we explore the possible relationship among those factors and degree of wound healing. RESULTS The median level of serum MMP-9 in good healers was lower than poor healers at first visit (124.2 μg/L vs 374.6 μg/L, p<0.05), and after 4-week therapy it decreased 5-fold approximately. In contrast, the change in MMP-9 concentration did not reach statistical significance in poor healers. MMP-2, TIMP-1 and TIMP-2 varied slightly in both good healers and poor healers. The MMP-9/TIMP-1 ratio better reflected the healing than MMP-9 alone before therapy and after 4 week treatment (r = -0.6475 vs -0.3251, r = -0.7096 vs -0.1231, respectively). Receiver Operator Curve (ROC) showed that the cutoff for MMP-9/TIMP-1 ratio at <0.395 best predicted a reduction in wound area of 82% at the end of 4-week treatment with a sensitivity of 63.6% and a specificity of 58.6% (area under the curve 0.658, p < 0.001). CONCLUSIONS Detecting serum MMP-9/TIMP-1 ratio on admission might be a predictor of healing and might provide a novel target for the future therapy in diabetic foot ulcers.

[1]  M. Tsang,et al.  Human epidermal growth factor enhances healing of diabetic foot ulcers. , 2003, Diabetes care.

[2]  D. Armstrong,et al.  Classification of diabetic foot wounds. , 1997, Ostomy/wound management.

[3]  H. Lehnert,et al.  Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients , 2002, Diabetologia.

[4]  J. Giurini,et al.  Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial. , 2003, Plastic and reconstructive surgery.

[5]  S. Halimi,et al.  Matrix metalloproteinases and diabetic foot ulcers: the ratio of MMP-1 to TIMP-1 is a predictor of wound healing , 2008, Diabetic medicine : a journal of the British Diabetic Association.

[6]  H. Lehnert,et al.  Expression of matrix metalloproteinases and growth factors in diabetic foot wounds treated with a protease absorbent dressing. , 2006, Journal of diabetes and its complications.

[7]  C. Brinckerhoff,et al.  Molecular targets in osteoarthritis: metalloproteinases and their inhibitors. , 2007, Current drug targets.

[8]  M. Fishbein,et al.  Cartilaginous metaplasia in calcified diabetic peripheral vascular disease: morphologic evidence of enchondral ossification. , 2003, Human pathology.

[9]  D. Muir,et al.  Ratios of activated matrix metalloproteinase‐9 to tissue inhibitor of matrix metalloproteinase‐1 in wound fluids are inversely correlated with healing of pressure ulcers , 2002, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[10]  Paul G Scott,et al.  Pathophysiology of chronic nonhealing wounds. , 2005, The Journal of burn care & rehabilitation.

[11]  G. Schultz,et al.  Proteases and the diabetic foot syndrome: mechanisms and therapeutic implications. , 2005, Diabetes care.

[12]  V. Nube,et al.  Increased Matrix Metalloproteinase-9 Predicts Poor Wound Healing in Diabetic Foot Ulcers , 2009, Diabetes Care.

[13]  T. Cawston,et al.  Understanding the role of tissue degrading enzymes and their inhibitors in development and disease. , 2006, Best practice & research. Clinical rheumatology.

[14]  C. Bachert,et al.  Predictive and monitoring value of matrix metalloproteinase‐9 for healing quality after sinus surgery , 2004, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[15]  P. Tsao,et al.  Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress. , 2001, Circulation research.

[16]  Jason L Johnson,et al.  Genetic strategies to elucidate the roles of matrix metalloproteinases in atherosclerotic plaque growth and stability. , 2005, Circulation research.